However, recently, it was reported that phosphatase activity of PTEN increases IGF1R expression which enhances melanoma cells resistance to vemurafenib and targeting IGF1R could be useful in melanoma patients with PTEN-positive tumors to overcome therapy resistance [236]. Here, PTEN is linked to melanoma.